Skip to the ledger

GrantClerk

NSF award 2528222 · Foli BIO INC.

SBIR Phase I: Development of a High-Throughput Fecal Exfoliome Analyzing Platform for Clinical Drug Development

Final report due

28 January 2027

in 102 days · The award ends on 30 September 2026.

GrantClerk is a private service. We are not NSF or any government agency.

Dates this award owes

NSF emails you about this too.

  • Final report due28 Jan 2027in 102 days

    award ending 2026-09-30 · Research.gov

  • Project outcomes report due28 Jan 2027in 102 days

    award ending 2026-09-30 · Research.gov

  • Award is closed out28 Jan 2027in 102 days

    award ending 2026-09-30 · Research.gov

Annual report dates come from the budget period on your award notice. That date is not public, so it is not shown here.

How we got this date

  1. NSF lists this award's end date as 30 September 2026.
  2. NSF rules say the final report is due no later than 120 days after that.
  3. So the final report is due by 28 January 2027.

Read the rule on Research.gov

Get a note before each report date

Add this award to your desk. We email you before each date and keep the dates in one place.

Renews each year until you cancel. Cancel any time from your account.

Already a member? Sign in

Award card

Award number
2528222
Period of support
1 Oct 2025 – 30 Sep 2026
Amount
$305,000
Awardee
Foli BIO INC., NEW York, NY
Program
SBIR Phase I
Directorate
TIP

Abstract

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project lies in enabling pharmaceutical companies to better evaluate and tailor treatments for inflammatory bowel disease (IBD), a chronic condition that affects over 3 million people in the United States. Drug development for IBD is hindered by the lack of scalable, non-invasive tools for monitoring disease activity…

Is this right?

We copy this from the public NSF award record. Your award notice and NSF always win. If a date looks wrong, check Research.gov.